VIPR1 and shigellosis: Felegary et al. prepared recombinant chimeric protein IgY antibodies targeting Shigellosis antigens IpaD, IpaB, StxB, and VirG, and assessed the preventive efficacy of IgY by immunizing mice and subsequently challenging them with the virus.